XML 26 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheet Details
12 Months Ended
Jul. 31, 2013
Balance Sheet Details [Abstract]  
Balance Sheet Details

3. Balance Sheet Details 

 

Inventories consist of the following: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

July 31,

 

2013

 

2012

Raw materials

$

70,000 

 

$

476,000 

Finished goods

 

295,000 

 

 

178,000 

 

$

365,000 

 

$

654,000 

 

 

 

Given our current focus on near term commercialization of the SDC-based products used to provide solutions for the food safety industry, we believe there is no net realizable value for numerous current product configurations.  Therefore, as of the fiscal year ended July 31, 2013, we established an inventory reserve for $347,000.  The majority of the reserve relates to components such as, plastic bottles, spray triggers, miscellaneous plastics, and numerous corrugated cardboard configurations.  

 

In addition, during the year ended July 31, 2013, we received $58,000 from the sale of silver held in inventory. At the time of sale, the silver had a book value of $40,000. The corresponding $18,000 gain is reflected in the other income (expense) section of the 2013 consolidated statement of operations.

 

Property, plant, and equipment consist of the following: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

July 31,

 

2013

 

2012

Computers and equipment

$

921,000 

 

$

909,000 

Furniture and fixtures

 

21,000 

 

 

21,000 

Leasehold improvements

 

622,000 

 

 

622,000 

 

 

1,564,000 

 

 

1,552,000 

Less accumulated depreciation

 

(1,418,000)

 

 

(1,295,000)

 

$

146,000 

 

$

257,000 

 

 

Depreciation expense was $123,000 and $179,000 for the years ended July 31, 2013 and 2012, respectively.   

 

Patents consist of the following: 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

July 31,

 

2013

 

2012

Patents

$

3,389,000 

 

$

3,773,000 

Less accumulated amortization

 

(1,959,000)

 

 

(1,823,000)

 

$

1,430,000 

 

$

1,950,000 

 

Due to the significant changes in our strategic business objectives and utilization of our assets, we have determined cost associated with the pending patent applications in numerous foreign geographic locations have been impaired.  As a result, during the year ended July 31, 2013, we reduced the carrying value of our patents and recorded a $551,000 patent impairment. 

 

Patent amortization expense was $188,000 and $206,000 for the years ended July 31, 2013 and 2012, respectively. At July 31, 2013, the weighted average remaining amortization period for all patents was approximately ten years. The annual patent amortization expense for the next five years is estimated to be approximately $152,000 per year.